Publications by authors named "S Maraghi"

Tranexamic acid (TXA) is an antifibrinolytic agent that is considered as one of the latest interventions currently being investigated in the field of facial aesthetic surgeries, as it is predicted to be effective in reducing intraoperative and postoperative complications of facial aesthetic surgeries. This review focuses on giving readers a comprehensive overview regarding the use of TXA in facial aesthetic surgeries. In this umbrella review, data were extracted from existing systematic reviews and meta-analysis that focused on the use of TXA in facial aesthetic surgeries.

View Article and Find Full Text PDF

Background: Compared to standard echocardiography, speckle tracking echocardiography (STE) looks more accurate for the detection of subclinical dysfunction of the myocardium. The aim of our work was to assess the value of STE in the diagnosis of subclinical ventricular dysfunction and as a prognostic index in sepsis patients.

Patients And Methods: An observational prospective study involving critically ill patients aged ≥ 18 years diagnosed with sepsis or septic shock.

View Article and Find Full Text PDF

The is a tumor suppressor gene that encodes for the BRCA1 protein, which plays a vital role in DNA repair, cell cycle regulation, and the maintenance of genomic stability. The BRCA1 protein interacts with a variety of other proteins that play essential roles in gene regulation and embryonic development. It is a large protein composed of multiple domains.

View Article and Find Full Text PDF
Article Synopsis
  • Extracorporeal membrane oxygenation (ECMO) is a critical life-support technique for patients with acute respiratory or cardiac failure when other treatments fail, requiring careful planning and specialized training for the medical team.* -
  • This text outlines the establishment of a neonatal ECMO program, reviewing processes and evaluating outcomes by comparing the first 11 patients treated with data from the Extracorporeal Life Support Organization (ELSO) registry to ensure effective implementation.* -
  • Findings showed that the new ECMO program, treating both neonatal and pediatric patients, achieved clinical outcomes and mechanical complication rates comparable to national standards, indicating the program's successful launch and operation.*
View Article and Find Full Text PDF

Aims: Toxoplasma gondii is an obligate intracellular, protozoan that causes a high incidence of serious zoonotic parasitic disease in humans. In the present study the immune-protective efficacy of a DNA vaccine encoding SAG1 in combination with a gene sequence encoding FliC of Salmonella typhimurium (Toll-like receptor 5 agonist) was evaluated against acute T. gondii infection in mice.

View Article and Find Full Text PDF